Baltimore, Maryland–(Newsfile Corp. – June 7, 2021) – The Board and Management of Flavocure Biotech, Inc. (“Flavocure”) a drug discovery and development company, announced today the appointment of Dr Thomas F. Woolf, PhD, an expert in pharmaceutical sciences to the company’s Board of Advisors.
Read More about this Press Release on BIOSPACE.COM
Baltimore, Maryland–(Newsfile Corp. – June 7, 2021) – The Board and Management of Flavocure Biotech, Inc. (“Flavocure”) a drug discovery and development company, announced today
BALTIMORE, MARYLAND, August 27, 2020 – For Immediate Release – Flavocure Biotech, Inc. (“Flavocure”) a drug discovery and development company, announced today the appointment of David
Abstract Pancreatic cancer is particularly refractory to modern therapies, with a 5-year survival rate for patients at a dismal 8%. One of the significant barriers
Flavocure Biotech Inc. aims to be a leader in transforming natural products into new cures for patients.
Get all latest news from Flavocure Biotech
One Response
Congratulations, Great job